A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid

4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective. Combining the dynamics of cerebrospinal fluid, our study investigates the clinical effects of syringomyelia after the combination of fourth ventricle-subarachnoid shunt (FVSS) for recurrent Chiari (type I) malformations after cranial fossa decompression (foramen magnum decompression (FMD)). Methods. From December 2018 to December 2020, 15 patients with recurrent syringomyelia following posterior fossa decompression had FVSS surgery. Before and after the procedure, the clinical and imaging data of these individuals were retrospectively examined. Results. Following FVSS, none of the 15 patients experienced infection, nerve injury, shunt loss, or obstruction. 13 patients improved dramatically after surgery, while 2 patients improved significantly in the early postoperative period, but the primary symptoms returned 2 months later. The Japanese Orthopedic Association (JOA) score was 12.67±3.95, which was considerably better than preoperatively (t=3.69, P0.001). The MRI results revealed that the cavities in 13 patients were reduced by at least 50% compared to the cavities measured preoperatively. The shrinkage rate of syringomyelia was 86.67% (13/15). One patient's cavities nearly vanished following syringomyelia. The size of the cavity in the patient remain unchanged, and the cavity's maximal diameter was significantly smaller than the size measured preoperatively (P<0.001) PC-MRI results indicated that the peak flow rate of cerebrospinal fluid at the central segment of the midbrain aqueduct and the foramen magnum in patients during systole and diastole were significantly reduced after surgery (P<0.05). Conclusion. After posterior fossa decompression, FVSS can effectively restore the smooth circulation of cerebrospinal fluid and alleviate clinical symptoms in patients with recurrent Chiari (type I) malformation and syringomyelia. It is a highly effective way of treatment.

References Powered by Scopus

Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep

659Citations
N/AReaders
Get full text

Inspiration is the major regulator of human CSF flow

281Citations
N/AReaders
Get full text

Treatment of syringomyelia associated with arachnoid scarring caused by arachnoiditis or trauma

190Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Fourth ventricle to spinal subarachnoid space stenting in pediatric patients with refractory syringomyelia: case series and systematic review

4Citations
N/AReaders
Get full text

Fourth ventricle stent placement for treatment of type I Chiari malformation in children

3Citations
N/AReaders
Get full text

Ependymal cilia decline and AQP4 upregulation in young adult rats with syringomyelia

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lou, Y., Yang, J., Gu, H., Xu, G., Ji, S., Xu, C., & Liu, Y. (2022). A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid. BioMed Research International, 2022. https://doi.org/10.1155/2022/9770323

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Professor / Associate Prof. 1

20%

Researcher 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

75%

Nursing and Health Professions 1

25%

Save time finding and organizing research with Mendeley

Sign up for free